Good afternoon, everyone, and thank you for joining us today to discuss Kyntra Bio, Inc.’s first quarter 2026 financial and business results. I am Gaia Vasiliver-Shamis from LifeSci Advisors. Joining ...
Silvercrest Asset Management Group Inc.’s total equity was $46.9 million at March 31, 2026. We had 7,666,844 shares of Class A common stock outstanding and 4,127,171 shares of Class B common stock ...
REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today reported financial results for the first quarter 2026, and provided an overview of recent business ...
Will Crypto Miners Pivot to AI? Latest on 3 Key Players Bitfarms (NASDAQ:BITF), now presenting as Keel Infrastructure, used its first-quarter 2026 earnings call to emphasize its shift from Bitcoin ...
Good day, and thank you for standing by. Welcome to AST SpaceMobile's First Quarter 2026 Business Update. Please be advised that today's call is being recorded. I will now turn the conference over to ...
Total Staking Rewards Since Inception Increase to 18,800 ETH as of May 4, 2026 Continues to Expand ETH Productivity Through Active Treasury Management and Onchain Deployments MIAMI, FL, May 11, 2026 ...
Ambow Education Holding Ltd. ('Ambow” or the 'Company”) (NYSE American: AMBO) a U.S.-based innovator of AI-powered phygital (physical + digital) solutions for education, corporate collaboration and ...
SES S.A. announces financial results for the three months ended 31 March 2026. Q1 2026 Performance (€ million) Q1 2026 as reported (1) Q1 2025 as ...
FS KKR Capital Corp. (NYSE: FSK), or the Company, today announced its financial and operating results for the quarter ended March 31, 2026 and announced certain strategic value enhancement actions, as ...
DocGo Inc. ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the first quarter ...
Detailed price information for Power Solutions International (PSIX-Q) from The Globe and Mail including charting and trades.
ABCL635 demonstrated a favorable tolerability profile, with no observed liver toxicity, and achieved potent and sustained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results